When is the Impella (Intra-Aortic Balloon Pump) device usually removed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Impella Device Removal Timing

The Impella device is typically removed when there is evidence of myocardial recovery, which occurs in approximately 72% of patients, with the average duration of support ranging from 2-3 days for most acute cases to up to several weeks for bridge-to-recovery or bridge-to-transplant cases. 1

Indications for Removal

  • Removal is indicated when hemodynamic parameters have normalized and there is evidence of adequate native cardiac function without mechanical support 2
  • For patients who received Impella for high-risk PCI, the device is typically removed at the bedside or in the catheterization laboratory immediately following the procedure 2
  • In cardiogenic shock cases, removal occurs when:
    • Vasopressor requirements have significantly decreased or been eliminated 1
    • Echocardiographic evidence shows improved ventricular function 3
    • End-organ perfusion has been restored with normalized lactate levels 3

Timing of Removal Based on Clinical Scenario

Post-PCI Support

  • For elective high-risk PCI cases, the Impella is typically removed immediately after the procedure or within 24 hours 2
  • The device can be safely removed at the bedside without surgical intervention 2

Cardiogenic Shock

  • In cardiogenic shock cases, the average duration of support is 2-3 days before removal 1
  • Removal occurs when:
    • Hemodynamic stability is achieved without significant inotropic support 3
    • Evidence of myocardial recovery is present on echocardiography 1
    • End-organ function has improved 3

Bridge to Recovery

  • For fulminant myocarditis or other potentially reversible causes of cardiogenic shock, the device may remain in place for 48-72 hours before removal 4
  • In some cases, the Impella may be used in combination with ECMO, with both devices typically removed within 48-72 hours once recovery is evident 4

Bridge to Decision or Bridge to Transplant

  • For patients awaiting heart transplantation or long-term VAD placement, the Impella 5.5 can remain in place for extended periods
  • Recent evidence shows successful use of Impella 5.5 for an average of 70 days (with maximum reported duration of 83 days) as a bridge to heart transplantation 5

Transition to Other Support Modalities

  • In approximately 8% of cases, patients are transitioned from Impella to long-term ventricular assist devices when recovery is not achieved 1
  • For patients with biventricular failure, the Impella may be removed and replaced with more comprehensive support systems like BiVAD or total artificial heart 3

Complications Affecting Removal Timing

  • Device malfunction, high purge pressures, tube fracture, or groin hematoma may necessitate earlier than planned removal in approximately 30% of cases 1
  • If thrombotic complications develop, immediate removal may be required 2

Monitoring During and After Removal

  • Close hemodynamic monitoring is essential during and after Impella removal to detect any deterioration requiring reinsertion or escalation of support 3
  • Echocardiographic assessment before, during, and after removal helps confirm adequate native cardiac function 3

Special Considerations

  • For Impella 2.5 devices (lower flow), earlier removal may be necessary if inadequate support is provided, particularly in patients with large body mass index or severe shock 2
  • For Impella 5.0/5.5 devices (higher flow), longer duration support is possible with lower complication rates compared to earlier generation devices 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Temporary Ventricular Assist Devices with Impella

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients.

ASAIO journal (American Society for Artificial Internal Organs : 1992), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.